{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:43:26Z","timestamp":1789548206361,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1007\/s12031-002-0012-8","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T17:49:12Z","timestamp":1181065752000},"page":"63-69","source":"Crossref","is-referenced-by-count":40,"title":["Development of a new treatment for alzheimer\u2019s disease and parkinson\u2019s disease using anti-aggregatory \u03b2-synuclein-derived peptides"],"prefix":"10.1007","volume":"19","author":[{"given":"Manfred","family":"Windisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Hutter-Paier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Rockenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Mallory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"12_CR1","first-page":"109","volume":"8","author":"R. Anand","year":"1996","unstructured":"Anand R., Gharabawi G., and Enz A. (1996) Efficacy and safety results of the early phase studies with Exelon TM (ENA-713) in Alzheimer\u2019s Disease: an overview. J. Drug Dev. Clin. Pract. 8, 109\u2013116.","journal-title":"J. Drug Dev. Clin. Pract."},{"issue":"44","key":"12_CR2","doi-asserted-by":"crossref","first-page":"34574","DOI":"10.1074\/jbc.M005514200","volume":"275","author":"A. L. Biere","year":"2000","unstructured":"Biere A. L., Wood S. J., Wypych J., Steavenson S., Jiang Y., Anafi D., et al. (2000) Parkinson\u2019s disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs. J. Biol. Chem. 275(44), 34574\u201334579.","journal-title":"J. Biol. Chem."},{"issue":"5\u20136","key":"12_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0361-9230(99)00136-7","volume":"50","author":"R. E. Burke","year":"1999","unstructured":"Burke R. E. (1999) \u03b1-Synuclein and Parkinson\u2019s disease. Brain Res. Bull. 50(5\u20136), 465\u2013466.","journal-title":"Brain Res. Bull."},{"key":"12_CR4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000017126","volume":"10","author":"A. Burns","year":"1999","unstructured":"Burns A., Rossor M., Hecker J., Gauthier S., Petit H., M\u00f6ller H. J., et al. (1999) The effects of Donepezil in Alzheimer\u2019s disease: results from a multinational trial. Dement. Geriatr. Cogn. Disord. 10, 237\u2013244.","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"12_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00002093-199509020-00005","volume":"9\/2","author":"J. Cummings","year":"1995","unstructured":"Cummings J., Ross W., Absher J., Gornbein J., and Hadjiaghai L. (1995) Depressive symptoms in Alzheimer Disease: assessment and determinants. Alzheimer Dis. Assoc. Disord. 9\/2, 87\u201393.","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"9","key":"12_CR6","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/archneur.57.9.1380","volume":"57","author":"D. Deleu","year":"2000","unstructured":"Deleu D. and Hanssens Y. (2000) Donepezil in the treatment of Alzheimer disease. Arch. Neurol. 57(9), 1380\u20131386.","journal-title":"Arch. Neurol."},{"issue":"2","key":"12_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4","volume":"61","author":"J. E. Duda","year":"2000","unstructured":"Duda J. E., Lee V. M. Y., and Trojanowski J. Q. (2000) Neuropathology of synuclein aggregates: new insights into mechanisms of neurodegenerative diseases. J. Neurosci. Res. 61(2), 121\u2013127.","journal-title":"J. Neurosci. Res."},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/archneur.1997.00550180013006","volume":"54","author":"R. L. Ernst","year":"1997","unstructured":"Ernst R. L., Hay J. W., Fenn C., Tinklenberg J., and Yesavage J. A. (1997) Cognitive function and the costs of Alzheimer disease: an exploratory study. Arch. Neurol. 54, 687\u2013693.","journal-title":"Arch. Neurol."},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","volume":"404","author":"M. B. Feany","year":"2000","unstructured":"Feany M. B. and Bender W. W. (2000) A drosophila model of Parkinson\u2019s disease. Nature 404, 394\u2013398.","journal-title":"Nature"},{"issue":"5","key":"12_CR10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/1531-8249(200005)47:5<632::AID-ANA11>3.0.CO;2-N","volume":"47","author":"G. Forloni","year":"2000","unstructured":"Forloni G., Bertani I., Calella A. M., Thaler F., and Invernizzi R. (2000) \u03b1-synuclein and Parkinson\u2019s disease: selective neurodegenerative effect of \u03b1-synuclein fragment on dopaminergic neurons in vitro and in vivo. Ann. Neurol. 47(5), 632\u2013640.","journal-title":"Ann. Neurol."},{"issue":"11","key":"12_CR11","first-page":"S10","volume":"54","author":"L. Fratiglioni","year":"2000","unstructured":"Fratiglioni L., Launer L. J., Andersen K., Breteler M. M. B., Copeland J. R. M., Dartigues J. F., et al. (2000) Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54(11), S10-S15.","journal-title":"Neurology"},{"issue":"2","key":"12_CR12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF03339896","volume":"12","author":"S. Giampaoli","year":"2000","unstructured":"Giampaoli S. (2000) Epidemiology of major age-related diseases in women compared to men. Aging Clin. Exp. Res. 12(2), 93\u2013105.","journal-title":"Aging Clin. Exp. Res."},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","volume":"290","author":"B. I. Giasson","year":"2000","unstructured":"Giasson B. I., Duda J. E., Murray I. V. J., Chen Q. P., Souza J. M., Hurtig H. I., et al. (2000) Oxidative damage linked to neurodegeneration by selective \u03b1-synuclein nitration in synucleinopathy lesions. Science 290, 985\u2013989.","journal-title":"Science"},{"key":"12_CR14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/exnr.1994.1022","volume":"125","author":"T. Giordano","year":"1994","unstructured":"Giordano T., Pan J. B., Monteggia L. M., Holzman T. F., Snyder S. W., Krafft G., et al. (1994) Similarities between \u03b2 Amyloid peptides 1\u201340 and 40-1: effects on aggregation, toxicity in vitro, and injection in young and aged rats. Exp. Neurol. 125, 175\u2013182.","journal-title":"Exp. Neurol."},{"issue":"20","key":"12_CR15","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1523\/JNEUROSCI.19-20-08876.1999","volume":"19","author":"D. M. Hartley","year":"1999","unstructured":"Hartley D. M., Walsh D. M., Ye C. P., Diehl T., Vasquez S., Vassilev P. M., et al. (1999) Protofibrillar intermediates of amyloid \u03b2-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19(20), 8876\u20138884.","journal-title":"J. Neurosci."},{"issue":"47","key":"12_CR16","doi-asserted-by":"crossref","first-page":"15514","DOI":"10.1021\/bi991161m","volume":"38","author":"K. Hasegawa","year":"1999","unstructured":"Hasegawa K., Yamaguchi I., Omata S., Gejyo F., and Naiki H. (1999) Interaction between A beta(1\u201342) and A beta(1\u201340) in Alzheimer\u2019s beta-amyloid fibril formation in vitro. Biochemistry 38(47), 15514\u201315521.","journal-title":"Biochemistry"},{"issue":"4","key":"12_CR17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1750-3639.1999.tb00552.x","volume":"9","author":"M. Hashimoto","year":"1999","unstructured":"Hashimoto M. and Masliah E. (1999) Alpha-synuclein in Lewy body disease and Alzheimer\u2019s disease. Brain Pathol. 9(4), 707\u2013720.","journal-title":"Brain Pathol."},{"issue":"2","key":"12_CR18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0006-8993(98)00514-9","volume":"799","author":"M. Hashimoto","year":"1998","unstructured":"Hashimoto M., Hsu L. J., Sisk A., Xia Y., Takeda A., Sundsmo M., et al. (1998) Human recombinant NACP\/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease. Brain Res. 799(2), 301\u2013306.","journal-title":"Brain Res."},{"issue":"4","key":"12_CR19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00001756-199903170-00011","volume":"10","author":"M. Hashimoto","year":"1999","unstructured":"Hashimoto M., Hsu L. J., Xia Y., Takeda A., Sisk A., Sundsmo M., et al. (1999) Oxidative stress induces amyloid-like aggregate formation of NACP\/alpha-synuclein in vitro. Neuroreport 10(4), 717\u2013721.","journal-title":"Neuroreport"},{"issue":"(2)","key":"12_CR20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0896-6273(01)00462-7","volume":"32","author":"M. Hashimoto","year":"2001","unstructured":"Hashimoto M., Rockenstein E., Mante M., Mallory M., and Masliah E. (2001) \u03b2-synuclein inhibits \u03b1-synuclein aggregation: A possible role as an anti-parkinsonian factor. Neuron 32(2), 213\u2013223.","journal-title":"Neuron"},{"key":"12_CR21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0925-4439(00)00036-3","volume":"1502","author":"A. Iwai","year":"2000","unstructured":"Iwai A. (2000) Properties of NACP\/\u03b1-synuclein and its role in Alzheimer\u2019s disease. Biochim. Biophys. Acta 1502, 95\u2013109.","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"12_CR22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A. Iwai","year":"1995","unstructured":"Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H. A., et al. (1995) The precursor protein of non-A beta component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron 14(2), 467\u2013475.","journal-title":"Neuron"},{"issue":"32","key":"12_CR23","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1021\/bi00032a006","volume":"34","author":"A. Iwai","year":"1995","unstructured":"Iwai A., Yoshimoto M., Masliah E., and Saitoh T. (1995) Non-A beta component of Alzheimer\u2019s disease amyloid (NAC) is amyloidogenic. Biochemistry 34(32), 10139\u201310145.","journal-title":"Biochemistry"},{"key":"12_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","volume":"345","author":"R. Jakes","year":"1994","unstructured":"Jakes R., Spillantini M. G., and Goedert M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 27\u201332.","journal-title":"FEBS Lett."},{"issue":"Pt 1","key":"12_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/bj3100091","volume":"310","author":"P. H. Jensen","year":"1995","unstructured":"Jensen P. H., Sorensen E. S., Petersen T. E., Gliemann J., and Rasmussen L. K. (1995) Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide. Biochem. J. 310(Pt 1), 91\u201394.","journal-title":"Biochem. J."},{"key":"12_CR26","first-page":"759","volume":"57","author":"H. Ji","year":"1997","unstructured":"Ji H., Liu Y. E., Jia T., Wang M., Liu J., Xiao G., et al. (1997) Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res. 57, 759\u2013764.","journal-title":"Cancer Res."},{"key":"12_CR27","doi-asserted-by":"crossref","unstructured":"Kanowski S. (1998) Cost-benefit evaluation of drug treatment for Alzheimer\u2019s disease. Arch. Gerontol. Geriatr. 275\u2013280.","DOI":"10.1016\/S0167-4943(98)80039-3"},{"issue":"7","key":"12_CR28","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.96.7.3342","volume":"96","author":"P. T. Lansbury","year":"1999","unstructured":"Lansbury P. T., Jr. (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. USA 96(7), 3342\u20133344.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12_CR29","first-page":"192","volume":"1","author":"E. Masliah","year":"1993","unstructured":"Masliah E. and Terry R. (1993) Role of synaptic pathology in the mechanisms of dementia in Alzheimer\u2019s Disease. Clin. Neurosci. 1, 192\u2013198.","journal-title":"Clin. Neurosci."},{"key":"12_CR30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-3940(94)90121-X","volume":"174","author":"E. Masliah","year":"1994","unstructured":"Masliah E., Mallory M., Hansen L., Deteresa R., Alford M., and Terry R. (1994) Synaptic and neuritic alterations during the progression of Alzheimer\u2019s disease. Neurosci. Lett. 174, 67\u201372.","journal-title":"Neurosci. Lett."},{"issue":"1","key":"12_CR31","first-page":"201","volume":"148","author":"E. Masliah","year":"1996","unstructured":"Masliah E., Iwai A., Mallory M., Ueda K., and Saitoh T. (1996) Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer\u2019s disease. Am. J. Pathol. 148(1), 201\u2013210.","journal-title":"Am. J. Pathol."},{"key":"12_CR32","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E. Masliah","year":"2000","unstructured":"Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., et al. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265\u20131269.","journal-title":"Science"},{"key":"12_CR33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(91)91553-D","volume":"563","author":"C. J. Pike","year":"1991","unstructured":"Pike C. J., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1991) In vitro aging of \u03b2-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311\u2013314.","journal-title":"Brain Res."},{"issue":"5321","key":"12_CR34","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"M. H. Polymeropoulos","year":"1997","unstructured":"Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321), 2045\u20132047.","journal-title":"Science"},{"key":"12_CR35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/089198879500800203","volume":"8\/2","author":"W. Reichman","year":"1995","unstructured":"Reichman W. and Coyne A. (1995) Depressive Symptoms in Alzheimer\u2019s Disease and multi-infarct dementia. J. Geriatr. Psychiatry Neurol. 8\/2, 96\u201399.","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"35","key":"12_CR36","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1021\/bi001315u","volume":"39","author":"J. C. Rochet","year":"2000","unstructured":"Rochet J. C., Conway K. A., and Lansbury P.T. Jr. (2000) Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein. Biochemistry 39(35), 10619\u201310626.","journal-title":"Biochemistry"},{"issue":"3","key":"12_CR37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0924-977X(00)00067-5","volume":"10","author":"S. L. Rogers","year":"2000","unstructured":"Rogers S. L., Doody R. S., Pratt R. D., and Ieni J. R. (2000) Long-term efficacy and safety of donepezil in the treatment of Alzheimer\u2019s disease: final analysis of a US multicentre open-label study. Eur. Neuropsychopharmacol. 10(3), 195\u2013203.","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"12_CR38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/oxfordjournals.epirev.a017933","volume":"19","author":"A. J. C. Slooter","year":"1997","unstructured":"Slooter A. J. C. and Van Duijn C. M. (1997) Genetic epidemiology of Alzheimer Disease. Epidemiol. Rev. 19(1), 107\u2013119.","journal-title":"Epidemiol. Rev."},{"issue":"6645","key":"12_CR39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"M. G. Spillantini","year":"1997","unstructured":"Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R., and Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645), 839\u2013840.","journal-title":"Nature"},{"issue":"2","key":"12_CR40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/mcne.1999.0735","volume":"13","author":"A. Surguchov","year":"1999","unstructured":"Surguchov A., Surgucheva I., Solessio E., and Baehr W. (1999) Synoretin: a new protein belonging to the synuclein family. Mol. Cell Neurosci. 13(2), 95\u2013103.","journal-title":"Mol. Cell Neurosci."},{"issue":"2","key":"12_CR41","first-page":"367","volume":"152","author":"A. Takeda","year":"1998","unstructured":"Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L., and Masliah E. (1998) Abnormal accumulation of NACP\/alpha-synuclein in neurodegenerative disorders. Am. J. Pathol. 152(2), 367\u2013372.","journal-title":"Am. J. Pathol."},{"key":"12_CR42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000110336","volume":"12","author":"T. Treves","year":"1993","unstructured":"Treves T., Chandra V., and Korczyn A. (1993) Parkinsons\u2019s and Alzheimer\u2019s Diseases: epidemiological comparison. Neuroepidemiology 12, 336\u2013344.","journal-title":"Neuroepidemiology"},{"issue":"10","key":"12_CR43","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.cdd.4400432","volume":"5","author":"J. Q. Trojanowski","year":"1998","unstructured":"Trojanowski J. Q., Goedert M., Iwatsubo T., and Lee V. M. (1998) Fatal attractions: abnormal protein aggregation and neuron death in Parkinson\u2019s disease and Lewy body dementia. Cell Death Differ. 5(10), 832\u2013837.","journal-title":"Cell Death Differ."},{"key":"12_CR44","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","volume":"90","author":"K. Ueda","year":"1993","unstructured":"Ueda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., et al. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 11282\u201311286.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12_CR45","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/089198879400700409","volume":"7","author":"St. Vida","year":"1994","unstructured":"Vida St., Des Rosiers P., Carrier L., and Gauthier S. (1994) Prevalence of depression in Alzheimer\u2019s Disease and validity of research diagnostic criteria. Geriatr. Psychiatry Neurol. 7, 238\u2013244.","journal-title":"Geriatr. Psychiatry Neurol."},{"issue":"1","key":"12_CR46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(97)00891-4","volume":"239","author":"K. Wakabayashi","year":"1997","unstructured":"Wakabayashi K., Matsumoto K., Takayama K., Yoshimoto M., and Takahashi H. (1997) NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson\u2019s disease. Neurosci. Lett. 239(1), 45\u201348.","journal-title":"Neurosci. Lett."},{"key":"12_CR47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1357-4310(00)01761-5","volume":"6","author":"E. E. Wanker","year":"2000","unstructured":"Wanker E. E. (2000) Protein aggregation in Huntington\u2019s and Parkinson\u2019s disease: implications for therapy. Mol. Med. Today 6, 387\u2013391.","journal-title":"Mol. Med. Today"},{"key":"12_CR48","unstructured":"Wilcock G. and Wilkinson D. (1997) Galanthamine hydrobromide: interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer type, in Alzheimer\u2019s Disease: Biology, Diagnosis and Therapeutics (Iqbal K., Winblad B., Nishimura T., Takeda M., and Wisniewski H. M., eds.), John Wiley & Sons Ltd., pp. 661\u2013664."},{"issue":"6","key":"12_CR49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archneur.57.6.793","volume":"57","author":"B. Wolozin","year":"2000","unstructured":"Wolozin B. and Behl C. (2000) Mechanisms of neurodegenerative disorders part 1: protein aggregates. Arch. Neurol. 57(6), 793\u2013796.","journal-title":"Arch. Neurol."},{"key":"12_CR50","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1073\/pnas.92.20.9141","volume":"92","author":"M. Yoshimoto","year":"1995","unstructured":"Yoshimoto M., Iwai A., Kang D., Otero D. A. C., Xia Y., and Saitoh T. (1995) NACP, the precursor protein of the non-amyloid \u03b2\/A4 protein (A\u03b2) component of Alzheimer disease amyloid, binds A\u03b2 and stimulates A\u03b2 aggregation. Proc. Natl. Acad. Sci. USA 92, 9141\u20139145.","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-002-0012-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-002-0012-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-002-0012-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:19:11Z","timestamp":1559427551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-002-0012-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":50,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s12031-002-0012-8","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}